Publications

Publications pour l'équipe Oncostat

Titre Publication Type Publication year Auteur
Revisiting vascular contraindications for transoral robotic surgery for oropharyngeal cancer journalArticle 2018 Gorphe, P.; Auperin, A.; Honart, J. F.; Ton Van, J.; El Bedoui, S.; Bidault, F.; Temam, S.; Kolb, F.; Qassemyar, Q.
[Network meta-analyses: Interest and limits in oncology] journalArticle 2016 Ribassin-Majed, L.; Pignon, J. P.; Michiels, S.; Blanchard, P.
Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase-mutated intrahepatic cholangiocarcinomas journalArticle 2018 Delahousse, J.; Verlingue, L.; Broutin, S.; Legoupil, C.; Touat, M.; Doucet, L.; Ammari, S.; Lacroix, L.; Ducreux, M.; Scoazec, J. Y.; Malka, D.; Paci, A.; Hollebecque, A.
In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies? journalArticle 2017 Aspeslagh, S.; Matias, M.; Palomar, V.; Dercle, L.; Lanoy, E.; Soria, J. C.; Postel-Vinay, S.
[Image-guided radiotherapy for head and neck carcinoma] journalArticle 2018 Beddok, A.; Blanchard, P.
[Prophylactic nodal radiotherapy in prostate cancer] journalArticle 2019 Bourdais, R.; Achkar, S.; Chauffert-Yvart, L.; Pasquier, D.; Sargos, P.; Blanchard, P.; Latorzeff, I.
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials journalArticle 2015 Paoletti, X.; Ezzalfani, M.; Le Tourneau, C.
Prognostic relevance of early radiologic response to induction chemotherapy in pediatric rhabdomyosarcoma: A report from the International Society of Pediatric Oncology Malignant Mesenchymal Tumor 95 study journalArticle 2018 Vaarwerk, B.; van der Lee, J. H.; Breunis, W. B.; Orbach, D.; Chisholm, J. C.; Cozic, N.; Jenney, M.; van Rijn, R. R.; McHugh, K.; Gallego, S.; Glosli, H.; Devalck, C.; Gaze, M. N.; Kelsey, A.; Bergeron, C.; Stevens, M. C. G.; Oberlin, O.; Minard-Colin, V.; Merks, J. H. M.
Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review journalArticle 2016 Gault, N.; Castaneda-Sanabria, J.; Guillo, S.; Foulon, S.; Tubach, F.
Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel-Lindau Gene Mutation Status journalArticle 2015 Messai, Y.; Gad, S.; Noman, M. Z.; Le Teuff, G.; Couve, S.; Janji, B.; Kammerer, S. F.; Rioux-Leclerc, N.; Hasmim, M.; Ferlicot, S.; Baud, V.; Mejean, A.; Mole, D. R.; Richard, S.; Eggermont, A. M.; Albiges, L.; Mami-Chouaib, F.; Escudier, B.; Chouaib, S.
Daily versus weekly prostate cancer image-guided radiotherapy: Phase 3 multicenter randomized trial journalArticle 2018 de Crevoisier, R.; Bayar, M. A.; Pommier, P.; Muracciole, X.; Pêne, F.; Dudouet, P.; Latorzeff, I.; Beckendorf, V.; Bachaud, J. M.; Laplanche, A.; Supiot, S.; Chauvet, B.; Nguyen, T. D.; Bossi, A.; Créhange, G.; Lagrange, J. L.
New insights into the evaluation of randomized controlled trials for rare diseases over a long-term research horizon: a simulation study journalArticle 2016 Bayar, M. A.; Le Teuff, G.; Michiels, S.; Sargent, D. J.; Le Deley, M. C.
C-Reactive Protein Values After Colorectal Resection: Can We Discharge a Patient With a C-Reactive Protein Value >100? A Retrospective Cohort Study journalArticle 2019 Benoit, O.; Faron, M.; Margot, N.; Creavin, B.; Debove, C.; Tiret, E.; Parc, Y.; Lefevre, J. H.
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials journalArticle 2015 Doussau, A.; Thiebaut, R.; Geoerger, B.; Schoffski, P.; Floquet, A.; Le Deley, M. C.; Mathoulin-Pelissier, S.; Rizzo, E.; Fumoleau, P.; Le Tourneau, C.; Paoletti, X.
Prognostic factors of successful on-purpose tumor biopsies in metastatic cancer patients included in the SHIVA prospective clinical trial journalArticle 2017 Desportes, E.; Wagner, M.; Kamal, M.; Salomon, A. V.; Deniziaut, G.; Pierron, G.; Rouleau, E.; Jouffroy, T.; Le Tourneau, C.; Paoletti, X.; Servois, V.
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study journalArticle 2016 Lueza, B.; Mauguen, A.; Pignon, J. P.; Rivero-Arias, O.; Bonastre, J.; Group, Mar-Lc Collaborative
Nail toxicities induced by systemic anticancer treatments journalArticle 2015 Robert, C.; Sibaud, V.; Mateus, C.; Verschoore, M.; Charles, C.; Lanoy, E.; Baran, R.
Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases journalArticle 2015 de Baère, T.; Aupérin, A.; Deschamps, F.; Chevallier, P.; Gaubert, Y.; Boige, V.; Fonck, M.; Escudier, B.; Palussiére, J.
Clinical evidence of variable proton biological effectiveness in pediatric patients treated for ependymoma journalArticle 2016 Peeler, C. R.; Mirkovic, D.; Titt, U.; Blanchard, P.; Gunther, J. R.; Mahajan, A.; Mohan, R.; Grosshans, D. R.
Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis journalArticle 2016 Chopra, H.; Arangalage, D.; Bouleti, C.; Zarka, S.; Fayard, F.; Chillon, S.; Laissy, J. P.; Henry-Feugeas, M. C.; Steg, P. G.; Vahanian, A.; Ou, P.
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial journalArticle 2015 Levy, A.; Azria, D.; Pignon, J. P.; Delarochefordiere, A.; Martel-Lafay, I.; Rio, E.; Malka, D.; Conroy, T.; Miglianico, L.; Becouarn, Y.; Malekzadeh, K.; Leclercq, J.; Juzyna, B.; Ezra, P.; Lemanski, C.; Deutsch, E.
Peritoneal Metastases from Colorectal Cancer: Treatment Principles and Perspectives journalArticle 2018 Goere, D.; Sourrouille, I.; Gelli, M.; Benhaim, L.; Faron, M.; Honore, C.
The 5000% case: a glimpse into the financial issue of lung cancer treatment journalArticle 2016 Remon, J.; Bonastre, J.; Besse, B.
Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort journalArticle 2016 Blanchard, P.; Wong, A. J.; Gunn, G. B.; Garden, A. S.; Mohamed, A. S.; Rosenthal, D. I.; Crutison, J.; Wu, R.; Zhang, X.; Zhu, X. R.; Mohan, R.; Amin, M. V.; Fuller, C. D.; Frank, S. J.
Systemic inflammatory disorders in patients admitted for aseptic meningitis journalArticle 2018 de la Motte, M. B.; Abbas, R.; Jouan, F.; van Gysel, D.; Chauveheid, M. P.; Papo, T.; Sacre, K.
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials journalArticle 2017 Arnold, D.; Lueza, B.; Douillard, J. Y.; Peeters, M.; Lenz, H. J.; Venook, A.; Heinemann, V.; Van Cutsem, E.; Pignon, J. P.; Tabernero, J.; Cervantes, A.; Ciardiello, F.
Anatomic Variability of the Upper Mediastinal Lymph Node Level VII journalArticle 2016 Hartl, D. M.; Breuskin, I.; Mirghani, H.; Berdelou, A.; Deandreis, D.; Pottier, E.; Borget, I.; Schlumberger, M.; Leboulleux, S.
Readressing the rationale of irradiation in stage I seminoma guidelines: a critical essay journalArticle 2019 Berghen, C.; Albersen, M.; Blanchard, P.; Bossi, A.; Briganti, A.; Cozzarini, C.; Decaestecker, K.; Fonteyne, V.; Haustermans, K.; Joniau, S.; Lim Joon, D.; Khoo, V.; Nguyen, P. L.; Ost, P.; Villeirs, G.; Vulsteke, C.; Zietman, A.; De Meerleer, G.
Radioactive iodine ablation in low-risk thyroid cancer - Authors' reply journalArticle 2018 Leboulleux, S.; Borget, I.; Schlumberger, M.
Enjeux méthodologiques de la médecine de précision en oncologie journalArticle 2017 Asselain, B.; Paoletti, X.
French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours: Perspective For Future Trends journalArticle 2015 Chouaid, C.; Borget, I.; Braun, E.; Bazil, M.; Schaetz, D.; Rémuzat, C.; Toumi, M.
Patients' perceived tolerance of side effects in phase I cancer clinical trials: A qualitative study journalArticle 2017 Bredart, A.; Bodson, S.; Le Tourneau, C.; Flahault, C.; Bonnetain, F.; Beaudeau, A.; Coquan, E.; Dolbeault, S.; Paoletti, X.
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study journalArticle 2016 Massard, C.; Oulhen, M.; Le Moulec, S.; Auger, N.; Foulon, S.; Abou-Lovergne, A.; Billiot, F.; Valent, A.; Marty, V.; Loriot, Y.; Fizazi, K.; Vielh, P.; Farace, F.
Sex specific associations in genome wide association analysis of renal cell carcinoma journalArticle 2019 Laskar, R. S.; Muller, D. C.; Li, P.; Machiela, M. J.; Ye, Y.; Gaborieau, V.; Foll, M.; Hofmann, J. N.; Colli, L.; Sampson, J. N.; Wang, Z.; Bacq-Daian, D.; Boland, A.; Abedi-Ardekani, B.; Durand, G.; Le Calvez-Kelm, F.; Robinot, N.; Blanche, H.; Prokhortchouk, E.; Skryabin, K. G.; Burdett, L.; Yeager, M.; Radojevic-Skodric, S.; Savic, S.; Foretova, L.; Holcatova, I.; Janout, V.; Mates, D.; Rascu, S.; Mukeria, A.; Zaridze, D.; Bencko, V.; Cybulski, C.; Fabianova, E.; Jinga, V.; Lissowska, J.; Lubinski, J.; Navratilova, M.; Rudnai, P.; Swiatkowska, B.; Benhamou, S.; Cancel-Tassin, G.; Cussenot, O.; Trichopoulou, A.; Riboli, E.; Overvad, K.; Panico, S.; Ljungberg, B.; Sitaram, R. T.; Giles, G. G.; Milne, R. L.; Severi, G.; Bruinsma, F.; Fletcher, T.; Koppova, K.; Larsson, S. C.; Wolk, A.; Banks, R. E.; Selby, P. J.; Easton, D. F.; Pharoah, P.; Andreotti, G.; Beane Freeman, L. E.; Koutros, S.; Albanes, D.; Mannisto, S.; Weinstein, S.; Clark, P. E.; Edwards, T. L.; Lipworth, L.; Carol, H.;
(18)F-fluorodeoxyglucose positron emission tomography to assess response after radiation therapy in anaplastic thyroid cancer journalArticle 2015 Levy, A.; Leboulleux, S.; Lepoutre-Lussey, C.; Baudin, E.; Ghuzlan, A. A.; Hartl, D.; Deutsch, E.; Deandreis, D.; Lumbroso, J.; Tao, Y.; Schlumberger, M.; Blanchard, P.
Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinic journalArticle 2018 Patrikidou, A.; Maroun, P.; Patard, J. J.; Baumert, H.; Albiges, L.; Massard, C.; Loriot, Y.; Escudier, B.; Di Palma, M.; Arfi-Rouche, J.; Rocher, L.; Merabet, Z.; Bossi, A.; Fizazi, K.; Blanchard, P.
Radiation-induced neurocognitive dysfunction in head and neck cancer patients journalArticle 2017 De Felice, F.; Blanchard, P.
Hypofractionation for prostate cancer: a word of caution journalArticle 2016 Bossi, A.; Blanchard, P.
Intramuscular administration of alfaxalone for sedation in rabbits journalArticle 2015 Huynh, M.; Poumeyrol, S.; Pignon, C.; Le Teuff, G.; Zilberstein, L.
Reply to V.P. Retel et al, D. Gauchan et al, and C. Rahilly-Tierney et al journalArticle 2015 Bonastre, J.; Marguet, S.; Lueza, B.; Michiels, S.; Delaloge, S.; Saghatchian, M.